Introduction Surgeons perform emergent exploratory laparotomies (ex-laps) for a myriad of surgical diagnoses. We characterized common diagnoses for which emergent ex-laps were performed and leveraged these groups to improve risk-adjustment models for postoperative mortality. Methods Using American Association for the Surgery of Trauma criteria, we identified hospitalizations where the primary procedure was an emergent ex-lap in the 2012-2014 (derivation cohort) and 2015 (validation cohort) Nationwide Inpatient Sample. After tabulating all ICD-9 diagnosis codes within these hospitalizations, we divided them into clinically-relevant groups. Using two stepwise regression paradigms – forward selection and backwards elimination – we identified diagnostic groups significantly associated with postoperative mortality in multivariable logistic regressions. We evaluated the addition of these groups as individual covariates in risk-adjustment models for postoperative mortality using the area under the receiver operator characteristic curve (AUROC). All regressions additionally adjusted for clinical factors and hospital clustering. Results We identified 4127 patients in the derivation cohort (median age: 50 years, 46.0% female, 62.1% white), with an overall mortality rate of 13.4%. Among all patients, we tabulated a total of 164 diagnosis codes, of which 27 (16.5%) may have led to an emergent ex-lap. These 27 codes clinically represented seven diagnostic categories, which captured a majority of the patients (70.4%). Backwards elimination and forward selection led to four common diagnosis categories associated with mortality: bleeding, obstruction, shock, and ischemia. Adjusting for these four diagnostic groups in a multivariable logistic regression assessing postoperative mortality increased the AUROC from 74.5% to 88.2% in the derivation cohort and from 73.8% to 88.2% in the validation cohort. Conclusion Seven diagnostic groups account for the majority of the emergent ex-laps. Adjusting for four groups may improve the accuracy of risk-adjustment models for mortality and validating such analytic standardization may optimize best research practices for EGS procedures. Evidence Level III, Prognostic and Epidemiologic Corresponding author: Joseph V. Sakran, MD, MPH, MPA, Department of Surgery, Division of Acute Care Surgery, Sheikh Zayed Tower, Suite 6107, Baltimore, MD 21287, Tel: 410-955-2244. Fax: 410-955-1884. Email: jsakran1@jhmi.edu © 2018 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2CRm9vr
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
-
http://bit.ly/2TO0eLw
-
Objectives: High-flow nasal cannula is increasingly used in the management of respiratory failure. However, little is known about its impact...
-
Abstract Background Emergency department (ED) acuity is the general level of patient illness, urgency for clinical intervention, and int...
-
Abstract Purpose To analyze the differences in outcomes between primary and secondary definitive osteosynthesis for fractures of the lower...
-
Oculo-Auriculo-Vertebral Dysplasia With Craniocervical Instability and Occult Tethered Cord Syndrome.... Oculo-Auriculo-Vertebral Dysplasia ...
-
Abstract Objective Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου